Secure payment on i-micronews Contact Yole Développement for I Micronews reports

RSS I-micronewsYole Dévelopement on TwitterYole Développement on Google +LinkedIn Yole pageSlideshare Yole Développement I-Micronews

Microfluidic Applications in the Pharmaceutical, Life Sciences, In Vitro Diagnostic and Medical Device Markets
Jun.2013

yole microfluidic app microfluidic device market june 2013 - web
5 990 €

Choose a minimum of three reports from Yole Group and receive a discount of at least 39% on your package – Contact us!


DESCRIPTION

Yole MicrofluidicApplications 2013 How life science and in vitro diagnostics applications are driving an impressive 27% growth for the microfluidic device market. 

Microfluidic applications in the pharmaceutical, life sciences, in vitro diagnostic and medical device markets report

 
The microfluidic device market is expected to reach $5.7B by 2018!
 
The microfluidic device market will grow swiftly, from $1.4B in 2013 to $5.7B by 2018. This impressive 27% growth will be fueled mainly by Pharmaceutical research and Point-of-Care applications. Facing new challenges, the healthcare industry is currently moving toward personalized medicine. In this context, the line between traditional markets (pharmaceutical and in vitro diagnostic markets) has blurred. More than ever, rapid, accurate tests are needed to increase pharmaceutical research yield and better monitor/cure patients.
 
By offering innovative solutions, microfluidic technologies have successfully managed to fill the gap. This new Yole Développement report provides a complete analysis of microfluidic device markets and technologies. Based on an accurate investigation of the last three years’ events, this report consolidates market data from 2010-2012 and provides forecasts for 2013-2018. Microfluidic devices can be produced either by pure microfluidics fabs or in-house by fully integrated players. After revealing the top 15 pure microfluidic fab players, the report looks at the “hidden” market linked to in-house production.
These microfluidic devices can either be used directly for some applications (analytical devices, flow chemistry, etc.) or must be completed by reagents/biological content. The distinction between the microfluidic device market (first-level package device) and the microfluidic technologybased test market has also been calculated.
 
Yole Microfluidic App Microfluidic device market June 2013 - web
Discover the microfluidic market’s complex organization, broken down in nine segments
 
Today, microfluidic devices are widely accepted in several applications. Nevertheless, the advantages and motivations for adopting microfluidic technologies are highly-dependent on the targeted application. For example, the added value of microfluidic devices in Point-of-Care applications depends on the associated small volume of necessary reagents, low-cost disposables and high sensibility. Contrarily, the advantages for pharmaceutical research applications are to allow process automation and multiplexed assays.

Yole Microfluidic App Market segmentation June 2013 - web
This report provides a market segmentation covering the following applications:
  • General dispensing
  • Drug delivery
  • Accurate dispensing
  • Analytical devices
  • Clinical and veterinary diagnostics
  • Point-of-care testing
  • Industrial and environmental testing
  • Pharmaceutical and life science
  • Microreaction technology
 
Each application is presented with market data, trends/drivers, key players and technologies used.
 
Recent changes in the material mix provide new opportunities for polymer and silicon
 
Different materials are used to manufacture microfluidic devices: glass, polymer, silicon, metal and ceramics. Whereas polymer is becoming the reference substrate for Point-Of-Care applications, glass is still the main substrate for analytical devices. The penetration rate of each substrate vs. Microfluidic application is presented in this report.
 
Yole Microfluidic App Material mix evolution provides June 2013 - web
Recently, the material mix has changed due to:
  • The need to reduce device cost for some applications (i.e. switching from glass to polymer)
  • The need to add new on-chip functions linked to emerging applications (i.e. growth of silicon use)
 
Material mix changes present exciting opportunities for new players entering the microfluidic market. For example, the high growth rate of next-generation sequencing technologies is opening new doors for silicon players. This report provides an analysis of these new opportunities, in line with material mix changes.

TABLE OF CONTENTS

Executive summary 4
Introduction 34
> Introduction
> Methodology
> Report objectives
> Companies cited in this report
> What’s new since 2011?

What’s Happened Since 2011 40
> 2011 microfluidic device market
> EMMA 2011 forecast vs. real market data
> 2012 microfluidic device market
> Market data versus EMMA 2011 forecasts
> Microfluidic device market – major changes
> New collaborations
> Acquisitions

Microfluidic Markets: 2011-2018 51
> Microfluidic markets introduction
> 2012 microfluidic players
> Microfluidic device market
> Market data: Our market vision
> Pure fab players: top 15
> Microfluidic chips market
> Microfluidic tests market

Microfluidic applications 89
Materials mix analysis 97
> Material mix for point-of-care testing
> Material mix for pharmaceutical and life science
> Silicon for pharmaceutical research chips

Microfluidic product description 105
> Information provided for each product class
> Flow control components and modules
> Microfluidic dispensing devices for drug delivery
> Microfluidic devices for accurate dispensing
> Microfluidics for analytical devices
> Cartridges for clinical and veterinary diagnostics
> Microfluidic devices for point-of-care
> Microfluidics for industrial and environmental testing
> Microfluidics for pharmaceutical and life science research
> Microfluidic devices for micro reactions

Emerging application 221
Microfluidic technologies 238
Microfluidics value chain 263
Microfluidics supply chain 271
Summary and conclusions

COMPANIES CITED


ABSCIEX
Abaxis
Abbott
Advion Biosciences
AES Laboratoire
Agilent Technologies
Bartels Mikrotechnik
BD
Bertin Technologies
Biodiot
BioFluidix
bioMérieux
Biosite
Boehringer Ingelheim
Bürkert
Caliper LifeSciences
Cellectricon
Cepheid
Cetoni
Cytoo
Dalsa
Danaher
Debiotech
Dolomite
Eksigent Technologies
Epocal
Fluidigm
Fluigent
GE Novasensor
GenePOC Genewave
GeSim
Great Basin
Hamilton
Ikerlan
Illumina
IMM
Invitrogen
Johnson & Johnson
Konica Minolta Opto
LabCyte
Life Technologies
MERLIN Diagnostika
MicroCHIPS
Micronit
Micro Parts
Nanostream
Ocusense
Pall Genesystem
PerkinElmer
Philips
Positive ID Corporation
Qiagen
Raindance Technologies
Roche Applied Science
Samsung
Scienion
Sensirion
Seyonic
Shimatzu
Biotech
Shrink Nanotechnologies
Siemens Medical Solutions
SonyDADC
Sophion
SpinChip Diagnostics
STMicroelectronics
Texas Instruments
Tokyo Electron
Vantix Ltd

 

KEY FEATURES OF THE REPORT

The report provides:

  • Market evolution and key events analysis for the last three years, including mergers & acquisitions, innovative product launches and collaborations
  • 2012-2018 microfluidic device forecast, with a unique market segmentation for each application
  • Material mix analysis underlining new opportunities for silicon
  • Detailed supply chain and value chain analysis, providing evidence for material value and structure across the entire value chain
  • micro